Results for tag: "Tauopathy Drug"

Tauopathy drugs are a class of drugs used to treat diseases of the central nervous system (CNS) that are caused by the accumulation of tau proteins in the brain. These diseases, known as tauopathies, include Alzheimer's disease, frontotemporal dementia, and progressive supranuclear palsy. Tauopathy drugs are designed to reduce the amount of tau proteins in the brain, thereby slowing the progression of the disease. Tauopathy drugs are a relatively new class of drugs, and there are currently only a few drugs approved for use in the treatment of tauopathies. These drugs are typically administered orally or intravenously, and they are often used in combination with other treatments such as cognitive behavioral therapy and lifestyle modifications. Companies in the tauopathy drug market include Biogen, AbbVie, and Novartis. Other companies, such as Merck, are also researching and developing tauopathy drugs. Show Less Read more